# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-21-130769
Filing Date
2021-10-28
Accepted
2021-10-28 09:28:15
Documents
21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-1/A | tm2123577-11_s1a.htm | S-1/A | 1997050
2 | EXHIBIT 1.1 | tm2123577d12_ex1-1.htm | EX-1.1 | 354589
3 | EXHIBIT 4.2 | tm2123577d12_ex4-2.htm | EX-4.2 | 115004
4 | EXHIBIT 10.2 | tm2123577d12_ex10-2.htm | EX-10.2 | 100037
5 | EXHIBIT 10.3 | tm2123577d12_ex10-3.htm | EX-10.3 | 102801
6 | EXHIBIT 10.4 | tm2123577d12_ex10-4.htm | EX-10.4 | 99103
7 | EXHIBIT 23.1 | tm2123577d12_ex23-1.htm | EX-23.1 | 3887
8 | GRAPHIC | lg_nuvectispharma-4clr.jpg | GRAPHIC | 21088
9 | GRAPHIC | lg_pwc-4c.jpg | GRAPHIC | 7237
10 | GRAPHIC | tm2123577d1-fc_1fig4clr.jpg | GRAPHIC | 140428
11 | GRAPHIC | tm2123577d1-fc_2fig4c.jpg | GRAPHIC | 283040
12 | GRAPHIC | tm2123577d1-lc_4fig4clr.jpg | GRAPHIC | 89913
13 | GRAPHIC | tm2123577d1-org_5fig4clr.jpg | GRAPHIC | 85795
14 | GRAPHIC | tm2123577d1-pht_6fig4clr.jpg | GRAPHIC | 171612
15 | GRAPHIC | tm2123577d1-tbl_4fig4clr.jpg | GRAPHIC | 80759
16 | GRAPHIC | tm2123577d12_ex23-1img001.jpg | GRAPHIC | 2142
17 | GRAPHIC | tm2123577d2-fc_target4clr.jpg | GRAPHIC | 118768
18 | GRAPHIC | tm2123577d2-lc_potent4clr.jpg | GRAPHIC | 244804
19 | GRAPHIC | tm2123577d2-lc_tumor4clr.jpg | GRAPHIC | 179913
20 | GRAPHIC | tm2123577d2-pht_inhibit4clr.jpg | GRAPHIC | 103383
21 | GRAPHIC | tm2123577d5-tbl_nuvectis4c.jpg | GRAPHIC | 86441
| Complete submission text file | 0001104659-21-130769.txt |  | 4996289

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

EIN.: 862405608 | State of Incorp.: DE
Type: S-1/A | Act: 33 | File No.: 333-260099 | Film No.: 211355526
SIC: 2834 Pharmaceutical Preparations